Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51 | 125 | 157 | 149 | 143 |
| Receivables | N/A | N/A | 2 | N/A | N/A |
| TOTAL | $54 | $137 | $171 | $149 | $143 |
| Non-Current Assets | |||||
| PPE Net | 4 | N/A | N/A | N/A | N/A |
| Intangibles | 615 | 0 | 0 | 0 | 0 |
| TOTAL | $619 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $673 | $137 | $171 | $149 | $143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 127 | 35 | 36 | 47 | 35 |
| Accrued Expenses | 3 | 16 | 10 | 20 | 16 |
| TOTAL | $1,270 | $470 | $436 | $379 | $531 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,270 | $470 | $436 | $379 | $531 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111 | 69 | 65 | 59 | 39 |
| Common Shares | 198 | 134 | 127 | 102 | 74 |
| Retained earnings | -9,081 | -8,434 | -8,240 | -7,723 | -7,428 |
| Other shareholders' equity | 1 | 1 | 4 | 0 | 0 |
| TOTAL | $-597 | $-333 | $-265 | $-231 | $-388 |
| Total Liabilities And Equity | $673 | $137 | $171 | $149 | $143 |